Loading candles…
Ortin Global Ltd., initially incorporated in 1986 as Ortin Laboratories Ltd, underwent rebranding to its current name around late 2024 to early 2025. The company operates primarily in the pharmaceutical and healthcare industries within India. It is engaged in manufacturing and trading pharmaceutical products, including pharmaceutical formulations, Active Pharmaceutical Ingredients (APIs), and intermediate formulations. Its product range covers therapeutic segments such as anti-diabetics, anti-retrovirals, and anti-pyretics. Ortin Global Ltd. focuses on serving the pharmaceutical and healthcare sector in India. No information about founders, key management, subsidiaries, notable projects, or stock exchange listings is available.
| Results - FY25 |
| To consider and approve the financial results for the period ended March 31, 2025 |
| 26 May 2025 |
Besseggen InfoTech LLP is a SEBI-registered stock broker (Reg. No. INZ000213450), member of NSE (90155 (Cash & F&O)) and BSE (6722 (Cash & F&O)). Investment in securities market are subject to market risks; read all related documents carefully before investing.